News
Roche has said it will let researchers have access to more data on its influenza vaccine Tamiflu, apparently under pressure from campaigners who have criticised the Swiss pharma company.
The Basel-based firm has been the subject of calls from theBritish Medical Journal and the Cochrane Collaborationto release more data on the drug. The organisations have been conducting a public ding-dong for more than a year over access to complete trial findings.
McGill Universityresearchers and colleagues discovered a protein abnormality linked to symptoms ofautismin mice. Interestingly, as Bloomberg reports, the scientists were able to use an experimental cancer drug to successfully reverse some of the autistic-like behaviors.
Details are published in the journal Nature.
Duke University scientists and their colleagues have concocted a new way to combat tumors. In short, they successfully tested a nontoxic injectable polymer in mice that eliminates the need for surgical implantation of radioactive seeds.
The journal Cancer Research published details of the finding. As HealthDay News and Ivanhoe Newswire report, the researchers focused their studies in mice that carried either human head and neck cancer, or prostate cancer. Simply put, they injected into the tumors a radioactive peptide polymer solution that responded to heat. Once injected, the material spontaneously assembled into radioactive seeds.
Researchers in Austria were able to both identify and isolate adult pancreatic stem cells, and then trigger their transformation into functioning,insulin-producing cells that behaved in response to glucose, Medical News Today reports. After initial success in a test tube, the team also generated promising results in mice.
Scientists believe they've cracked the code to a rare variation of childhood leukemia, and the key involves an abnormal gene.
Researchers at St. Jude's Children's Research Hospital and Washington University jointly pursued the research, which is highlighted in detail in the journal Cancer Cell. And their finding could lead to better diagnostic tools and new treatments for patients with acute megakaryoblastic leukemia (AMKL), which affects 10 of children with pediatricacute myeloid leukemia.